A Safety and Pharmacokinetic Study of Proellex® - Contacts and Locations

Home

A Safety and Pharmacokinetic Study of Proellex® (PK)

This study has been completed.

Study NCT00619385. Last updated on October 31, 2008. Information provided by Repros Therapeutics Inc.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00619385

Locations


United States, Texas
	Healthcare Discoveries Inc.
	San Antonio, Texas, United States, 78209

Sponsors and Collaborators

Repros Therapeutics Inc.